Introduction
Introduction

Cardiovascular diseases including myocardial infarction and heart failure are the most frequent causes of death in the industrialized world. While the current pharmacotherapy for congestive heart failure (which includes angiotensin converting enzyme inhibitors and ␤-blockers) improves clinical outcome, these treatment modalities as well as various interventional and surgical therapeutic methods have limited efficacy because of their inability to repair or replace damaged myocardium. Given the high morbidity and mortality rates associated with these major diseases, shortage of donor hearts for transplantation, complications resulting from immunosuppression and long-term failure of transplanted organs
, novel therapeutic means for improving cardiac function and preventing heart failure are in critical demand. Regeneration or repair of the damaged myocardium can be accomplished by the use of cell therapy, which is the transplantation of healthy, functional and propagating cells to restore the viability or function of deficient tissues [3] [4] [5] . In this regard, many studies have shown that improvement of myocardial function can be achieved in experimental animal models of heart failure and infarction, by transplanting embryonic stem cells-derived cardiomyocytes into the compromised myocardium [6] [7] [8] .
A [9, 10] [10] . [11, 12] 
novel potential source for cardiac cell regeneration is cardiomyocytes derived from human inducible pluripotent stem (iPS) cells generated from skin fibroblasts. Hence, thanks to the
Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells breakthrough inventions of Yamanaka and coworkers
In order to improve the prospects of cardiac cell transplantation, it is widely realized that the functional properties as well as the hormonal and pharmacological responsiveness of iPS-derived cardiomyocytes (iPS-CM) should be thoroughly investigated. Since it is preferred that the transplanted cells fully integrate within the malfunctioning myocardium, contribute to its contractile performance and respond appropriately to various stimuli (e.g. ␤-adrenergic stimulation), it is important to decipher their compatibility with the host myocardium. Since thus far, only the basic electrophysiological properties (at the action potential level) of iPS-CM were studied
Methods
Establishing the reprogramming system
Generation of inducible pluripotent stem cells iPS cells were generated from human foreskin fibroblasts (HFF) as previously described [9, 10] [14] .
Differentiating iPS colonies to cardiomyocytes
The iPS cells were cultured and differentiated using the same protocol used for the culture and differentiation of hESC [15] 
Dissociation of contracting EBs
dL/dtContrac is the maximum derivative of the line that represents the cell movement during the contraction (measured with the edge detector). dL/dtRelax is the maximum derivative of the line that represents the cell movement during relaxation.
The micro-electrode-array data acquisition system
Unipolar electrograms were recorded from iPS-CM plated on microelectrode arrays (MEAs) (Multi Channel Systems, Reutlingen, Germany) as previously described [17, 18] [11] [12] 19] .
Results
Generation of iPS cells
Molecular characterization of iPS-CM
To further characterize iPS-CM, immunofluorescence staining was performed on micro-dissected contracting areas, and on cardiomyocytes dissociated thereof. As illustrated in Fig. 2B 
The inotropic responsiveness of iPS-CM to ␤-adrenergic stimulation
In order to determine whether iPS-CM are responsive to ␤-adrenergic stimulation, we generated concentration-response relations of the effect of isoproterenol on the contraction parameters. In support of the functionality of the ␤-adrenergic signalling pathway, isoproterenol caused (within 2-3 min.) a marked concentration-dependent positive inotropic effect (Fig. 3D). To establish whether the inotropic response is developmentally regulated, we analysed the effect of isoproterenol on the contraction parameters in two age groups: 10-15-and 18-70-day-old iPS-CM. As seen in Fig. 3E, in both age groups isoproterenol caused a significant (P Ͻ 0.05) increase in the maximal rates of contraction and relaxation, and in the contraction amplitude. Although for all three contraction parameters, the older group appears more responsive, only for the maximal rate of contraction (dL/dtmax) the difference was statistically different (P Ͻ 0.05). In view of these findings, in
future studies we will explore the mechanisms underlying the developmental changes in the ␤-adrenergic responsiveness.
Recording extracellular electrograms from iPS-CM
Unipolar electrograms were recorded from iPS-CM plated on
MEAs as previously described [17, 18] (Fig. 5A-D) . Please note that the discontinuous traces in Fig. 5A-D (Fig. 5E ). (10 M) , which at this 'blocking' concentration, causes a prominent negative inotropic effect [22, 23] . As depicted by a representative experiment (Fig. 7A) in a 60-day-old EB, ryanodine caused a prominent negative inotropic effect which was partially reversible, supporting the notion of a functional SR. Since in our recent study [15] (Fig. 7B) . As shown by the summary (Fig. 7C) [24, 25] . As shown in 10-day-old iPS-CM from clone 2 (Fig. 7D) , and in the summary of four experiments (Fig. 7E) , caffeine (10 mM) caused a small (P Ͻ 0.05) increase in diastolic [Ca 2ϩ ]i. A similar response 5 and n ϭ 5-6, respectively) 
Hz. As depicted by the representative experiments, both in the iPS-CM clones investigated and in the hESC-CM clone H9.2 investigated, increasing the rate of stimulation caused a decrease in contraction amplitude
Post-rest potentiation in iPS-CM
we showed that ryanodine does not affect hESC-CM contraction recorded from intact EBs, in order to be compatible with the present work, we repeated these experiments in dissociated hESCderived EBs. As depicted by a representative experiment (Fig. 7B) in a 30-day-old hESC-CM clone H9.2 and in agreement with our previous work, ryanodine did not affect the contraction of dissociated hESC-derived EBs
Fig. 2 Molecular characterization of iPS-derived cardiomyocytes. (A) RT-PCR analysis of cardiac markers in iPS-derived cardiomyocytes clone C2. Undifferentiated cells and micro-dissected contracting areas from EBs, from both iPS and ES cells were analysed for their expression of cardiac mesoderm (T-box 5 [Tbx5] and T-box 20 [Tbx20]) and cardiac markers (cardiac troponin T and ␣-cardiac actin
Fig. 3 Simultaneous recordings of [Ca 2ϩ ]i transients and contractions of spontaneously contracting clones C1 and C2 iPS-derived cardiomyocytes and the effect of isoproterenol on iPS-derived cardiomyocytes clone C2. (A-C) Simultaneous recordings of [Ca 2ϩ ]i transients and the contraction in 29-and 60-day-old clone C2 iPS-derived cardiomyocytes (A, B) and a 60-day-old clone C1 iPS-derived cardiomyocytes (C). (D) A representative experiment illustrating an increase in contraction amplitude in response to increasing concentrations of isoproterenol (the preparation was 18-day-old and stimulated at 0.5 Hz). (E) A summary of the effects of isoproterenol on the contraction parameters of 10-15-and 18-70-day-old iPS-derived cardiomyocytes clone C2 (n ϭ
Molecular characterization of ES-like iPS colonies and iPS-CM
In agreement with previous reports [10, 11] we confirmed that our iPS clones represent ESC-like pluripotent cells by demonstrating that the colonies: (1) resemble in their morphology hESC (Fig. 1A) ; (Fig. 1D and E) . (Fig. 2A) . Further, immunofluorescence analysis of the contracting areas demonstrated that the cells were positive for ␣-sarcomeric actinin, cardiac troponin I and myosin heavy chain (Fig. 2B) . Importantly, in agreement with previous reports on cardiomyocytes derived from mouse and other human iPS clones [11] [12] 19] , we also found in iPS-CM organized sarcomeric structure. 
The basic functional properties of iPS-CM and ␤-adrenergic responsiveness
Functional properties of iPS-CM
Force-frequency relations
Resembling the behaviour of hESC-CM [15] and contrasted with the adult myocardium (including human heart) [26] , iPS-derived cardiomyocytes from both clones display negative FFRs (Fig. 5) ]i in both clones (Fig. 7) . To further test the [Ca] 2ϩ handling machinery in iPS-CM, we determined the immunofluorescence expression of ryanodine and calsequestrin (the latter shown to be absent in hESC-CM) [15, 25] . 
Post-rest potentiation in iPS-CM
